BRIDGEWATER, N.J., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) (Nasdaq: AMRX) today announced that the U.S. Food and Drug Administration (FDA) has ...

Amneal Pharmaceuticals received Food and Drug Administration approval for its albuterol sulfate inhalation aerosol to treat bronchospasm in people with reversible obstructive airway disease. The ...

A controversy erupted in Lok Sabha after a TMC MP was accused of using an e-cigarette, reigniting debate over vaping in India. Despite a nationwide ban, e-cigarettes remain a concern due to their ...

Amneal Pharmaceuticals recently received U.S. FDA approvals for its generic versions of RESTASIS® (cyclosporine ophthalmic emulsion 0.05%) and PROAIR® HFA (albuterol sulfate inhalation aerosol 90 mcg) ...

The "Inhaled Drugs Contract Manufacturing Market Forecast to 2033" has been added to ResearchAndMarkets.com's offering.

Acquisition of Vectura strengthened inhalation capabilities, driving innovation and portfolio expansion in less than one year Podium and poster presentations share research insights into inhalation ...

In May, the Mankato City Council declined to ban flavored nicotine products or impose a moratorium on new tobacco licenses.

Cooking sprays are easy to use, but they haven't always been the safest. To create the spray, many have used toxic ...